pharma_company
stringclasses 562
values | brand_name_en
stringlengths 19
232
| generic_name_en
stringlengths 21
250
| substance_name_en
stringclasses 983
values | atc_code_raw
stringclasses 778
values | anatomical_desc
stringclasses 14
values | therapeutic_desc
stringclasses 82
values | pharmacological_desc
stringclasses 181
values | subpharmacological_desc
stringclasses 365
values | chemical_desc
stringclasses 636
values |
---|---|---|---|---|---|---|---|---|---|
Sobhandarou
|
OLANZAPINE TABLET ORAL 5 mg
|
OLANZAPINE TABLET ORAL 5 mg
|
OLANZAPINE
|
N05AH03
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANTIPSYCHOTICS
|
Diazepines, oxazepines, thiazepines and oxepines
|
olanzapine
|
null |
BIPERIDEN (SHD) 2MG TAB TABLET ORAL 2 mg
|
BIPERIDEN HYDROCHLORIDE TABLET ORAL 2 mg
|
BIPERIDEN HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Dr. Abidi Pharmaceuticals
|
TAVANEX TABLET ORAL 500 mg
|
LEVOFLOXACIN TABLET ORAL 500 mg
|
LEVOFLOXACIN
|
J01MA12
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Fluoroquinolones
|
levofloxacin
|
Aani darman pharmaceutical Co.
|
HYOPOLAMINE TABLET ORAL 10 mg
|
HYOSCINE-N-BUTYL BROMIDE TABLET ORAL 10 mg
|
HYOSCINE-N-BUTYL BROMIDE
|
A03BB01
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
BELLADONNA AND DERIVATIVES, PLAIN
|
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
|
butylscopolamine
|
Sobhandarou
|
ABILIZOL TABLET ORAL 15 mg
|
ARIPIPRAZOLE TABLET ORAL 15 mg
|
ARIPIPRAZOLE
|
N05AX12
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANTIPSYCHOTICS
|
Other antipsychotics
|
aripiprazole
|
Astellas Pharma
|
PROGRAF CAPSULE ORAL 1 mg
|
TACROLIMUS CAPSULE ORAL 1 mg
|
TACROLIMUS
|
L04AD02
|
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
IMMUNOSUPPRESSANTS
|
IMMUNOSUPPRESSANTS
|
Calcineurin inhibitors
|
tacrolimus
|
Pursina Pharmaceutical Co.
|
GLIBENCLAMIDE TABLET ORAL 5 mg
|
GLIBENCLAMIDE TABLET ORAL 5 mg
|
GLIBENCLAMIDE
|
A10BB01
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS USED IN DIABETES
|
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
|
Sulfonylureas
|
glibenclamide
|
Jalinous Pharmaceutical Co.
|
TINIDAZOLE TABLET ORAL 500 mg
|
TINIDAZOLE TABLET ORAL 500 mg
|
TINIDAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Darou Pakhsh
|
PERPHENAZINE TABLET ORAL 4 mg
|
PERPHENAZINE TABLET ORAL 4 mg
|
PERPHENAZINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Shahid Ghazi Pharmaceutical Co.
|
LEVOFLOXACIN IN DEXTROSE INJECTION, SOLUTION INTRAVENOUS 5 mg/1mL 100 mL
|
LEVOFLOXACIN INJECTION, SOLUTION INTRAVENOUS 5 mg/1mL 100 mL
|
LEVOFLOXACIN
|
J01MA12
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Fluoroquinolones
|
levofloxacin
|
Pharmed Medical Industries
|
RENABAG S POWDER NOT APPLICABLE 650 g g
|
BICARBONATE CONCENTRATE POWDER NOT APPLICABLE 650 g
|
BICARBONATE CONCENTRATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Ramopharmin
|
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg
|
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg
|
OMEPRAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Rouzdarou
|
LEVOFLOXACIN TABLET ORAL 500 mg
|
LEVOFLOXACIN TABLET ORAL 500 mg
|
LEVOFLOXACIN
|
J01MA12
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Fluoroquinolones
|
levofloxacin
|
Farabi Pharmaceutical
|
CEFIXIME TABLET ORAL 400 mg
|
CEFIXIME TABLET ORAL 400 mg
|
CEFIXIME
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Toliddaru Pharma. Co.
|
MUCOLIN SOLUTION ORAL 4 mg/5mL 60 mL
|
BROMHEXINE HYDROCHLORIDE SOLUTION ORAL 4 mg/5mL 60 mL
|
BROMHEXINE HYDROCHLORIDE
|
R05CB02
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
|
Mucolytics
|
bromhexine
|
Behvazan Pharmaceutical
|
FLEETAZAN ENEMA RECTAL 7 g/19 g/118mL mm
|
SODIUM PHOSPHATE DIBASIC HEPTAHYDRATE / SODIUM PHOSPHATE MONOBASIC MONOHYDRATE ENEMA RECTAL 7 g/19 g/118mL
|
SODIUM PHOSPHATE DIBASIC HEPTAHYDRATE / SODIUM PHOSPHATE MONOBASIC MONOHYDRATE
|
A06AG01
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR CONSTIPATION
|
DRUGS FOR CONSTIPATION
|
Enemas
|
sodium phosphate
|
Raha Pharmaceutical Isfahan Company
|
IBUPROFEN TABLET ORAL 400 mg
|
IBUPROFEN TABLET ORAL 400 mg
|
IBUPROFEN
|
M01AE01
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Propionic acid derivatives
|
ibuprofen
|
Daana Pharma
|
AMPIVIL INJECTION, POWDER, FOR SOLUTION PARENTERAL 250 mg mg
|
AMPICILLIN INJECTION, POWDER, FOR SOLUTION PARENTERAL 250 mg
|
AMPICILLIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Toliddaru Pharma. Co.
|
DICLOFENAC SUPPOSITORY RECTAL 100 mg
|
DICLOFENAC SODIUM SUPPOSITORY RECTAL 100 mg
|
DICLOFENAC SODIUM
|
M01AB05
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Acetic acid derivatives and related substances
|
diclofenac
|
Tehran Darou Pharmaceutical Co.
|
VITAMIN A-TEDAGEL CAPSULE, LIQUID FILLED ORAL 50000 [iU]
|
VITAMIN A CAPSULE, LIQUID FILLED ORAL 50000 [iU]
|
VITAMIN A
|
A11CA01
|
ALIMENTARY TRACT AND METABOLISM
|
VITAMINS
|
VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO
|
Vitamin A, plain
|
retinol (vit A)
|
Faran Shimi Pharmaceutical Co.
|
FORBETMIN TABLET, EXTENDED RELEASE ORAL 500 mg
|
METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE ORAL 500 mg
|
METFORMIN HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Alborzdarou
|
OSTEOFOS TABLET ORAL 70 mg
|
ALENDRONATE SODIUM TABLET ORAL 70 mg
|
ALENDRONATE SODIUM
|
M05BA04
|
MUSCULO-SKELETAL SYSTEM
|
DRUGS FOR TREATMENT OF BONE DISEASES
|
DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
|
Bisphosphonates
|
alendronic acid
|
Rayhaneh Pharmaceutical Co.
|
PREGABALIN CAPSULE ORAL 100 mg
|
PREGABALIN CAPSULE ORAL 100 mg
|
PREGABALIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sobhandarou
|
IMIPRAMINE TABLET ORAL 50 mg
|
IMIPRAMINE HYDROCHLORIDE TABLET ORAL 50 mg
|
IMIPRAMINE HYDROCHLORIDE
|
N06AA02
|
NERVOUS SYSTEM
|
PSYCHOANALEPTICS
|
ANTIDEPRESSANTS
|
Non-selective monoamine reuptake inhibitors
|
imipramine
|
Jalinous Pharmaceutical Co.
|
PANZOL TABLET, DELAYED RELEASE ORAL 20 mg
|
PANTOPRAZOLE TABLET, DELAYED RELEASE ORAL 20 mg
|
PANTOPRAZOLE
|
A02BC02
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
pantoprazole
|
Toliddaru Pharma. Co.
|
METRONIDAZOLE SUPPOSITORY VAGINAL 500 mg
|
METRONIDAZOLE SUPPOSITORY VAGINAL 500 mg
|
METRONIDAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Exir Pharmaceutical Company
|
EXICORT INJECTION, POWDER, FOR SOLUTION PARENTERAL 100 mg mg
|
HYDROCORTISONE (AS SODIUM SUCCINATE) INJECTION, POWDER, FOR SOLUTION PARENTERAL 100 mg
|
HYDROCORTISONE (AS SODIUM SUCCINATE)
|
H02AB09
|
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
|
CORTICOSTEROIDS FOR SYSTEMIC USE
|
CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
|
Glucocorticoids
|
hydrocortisone
|
Tehran Chemie Pharmaceutical Co.
|
ANGIOVASC TABLET ORAL 5 mg
|
AMLODIPINE (AS BESILATE) TABLET ORAL 5 mg
|
AMLODIPINE (AS BESILATE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Zagros Darou Parsian
|
ACETAGROPHEN TABLET ORAL 500 mg
|
ACETAMINOPHEN TABLET ORAL 500 mg
|
ACETAMINOPHEN
|
N02BE01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol
|
Darou Pakhsh
|
PERPHENAZINE TABLET ORAL 8 mg
|
PERPHENAZINE TABLET ORAL 8 mg
|
PERPHENAZINE
|
N05AB03
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANTIPSYCHOTICS
|
Phenothiazines with piperazine structure
|
perphenazine
|
Cinnagen Co.
|
CINNOVEX INJECTION PARENTERAL 12000000 [iU]/1mL 0.5 [iU]
|
INTERFERON BETA-1A INJECTION PARENTERAL 12000000 [iU]/1mL 0.5 mL
|
INTERFERON BETA-1A
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
PANTOPRAZOLE TABLET, DELAYED RELEASE ORAL 20 mg
|
PANTOPRAZOLE TABLET, DELAYED RELEASE ORAL 20 mg
|
PANTOPRAZOLE
|
A02BC02
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
pantoprazole
|
NO.115 , Jalal St ., Esteqlal Town ,Tehran
|
ZITOCIDAL TABLET ORAL 250 mg
|
AZITHROMYCIN TABLET ORAL 250 mg
|
AZITHROMYCIN
|
J01FA10
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
|
Macrolides
|
azithromycin
|
Tehran Chemie Pharmaceutical Co.
|
DATICIN CAPSULE ORAL 150 mg
|
CLINDAMYCIN (AS HYDROCHLORIDE) CAPSULE ORAL 150 mg
|
CLINDAMYCIN (AS HYDROCHLORIDE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sobhan Oncology
|
ABIRATERONE ACETATE TABLET ORAL 250 mg
|
ABIRATERONE ACETATE TABLET ORAL 250 mg
|
ABIRATERONE ACETATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Darou Pakhsh
|
ACETAMINOPHEN SUPPOSITORY RECTAL 125 mg
|
ACETAMINOPHEN SUPPOSITORY RECTAL 125 mg
|
ACETAMINOPHEN
|
N02BE01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol
|
Samisaz
|
BISOTA TABLET ORAL 10 mg
|
BISOPROLOL FUMARATE TABLET ORAL 10 mg
|
BISOPROLOL FUMARATE
|
C07AB07
|
CARDIOVASCULAR SYSTEM
|
BETA BLOCKING AGENTS
|
BETA BLOCKING AGENTS
|
Beta blocking agents, selective
|
bisoprolol
|
Exir Pharmaceutical Company
|
OFLOXIR TABLET ORAL 300 mg
|
OFLOXACIN TABLET ORAL 300 mg
|
OFLOXACIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Alborzdarou
|
IVERMECTIN TABLET ORAL 6 mg
|
IVERMECTIN TABLET ORAL 6 mg
|
IVERMECTIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sobhan Oncology
|
BORTEZOMIB AQVIDA INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 3.5 mg mg
|
BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 3.5 mg
|
BORTEZOMIB
|
L01XX32
|
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
ANTINEOPLASTIC AGENTS
|
OTHER ANTINEOPLASTIC AGENTS
|
Other antineoplastic agents
| null |
Pharmachemie
|
CLOTRIMAZOLE-PHARMA CREAM VAGINAL 2 % 20 g
|
CLOTRIMAZOLE CREAM VAGINAL 2 % 20 g
|
CLOTRIMAZOLE
|
G01AF02
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
|
ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
|
Imidazole derivatives
|
clotrimazole
|
Shirazserum
|
RINGERS INJECTION, SOLUTION INTRAVENOUS 1000 mL
|
RINGERS INJECTION, SOLUTION INTRAVENOUS 147 meq/4.5 meq/4 meq/156 meq/1L 1000 mL
|
RINGERS
|
B05
|
BLOOD AND BLOOD FORMING ORGANS
|
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
| null | null | null |
Caspian Tamin Co.
|
INDIC SUPPOSITORY RECTAL 50 mg
|
INDOMETHACIN SUPPOSITORY RECTAL 50 mg
|
INDOMETHACIN
|
M01AB01
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Acetic acid derivatives and related substances
|
indometacin
|
Sobhandarou
|
VENLAXIN TABLET ORAL 37.5 mg
|
VENLAFAXINE TABLET ORAL 37.5 mg
|
VENLAFAXINE
|
N06AX16
|
NERVOUS SYSTEM
|
PSYCHOANALEPTICS
|
ANTIDEPRESSANTS
|
Other antidepressants
|
venlafaxine
|
Ramopharmin
|
ESOMEPRAZOLE CAPSULE, DELAYED RELEASE ORAL 40 mg
|
ESOMEPRAZOLE CAPSULE, DELAYED RELEASE ORAL 40 mg
|
ESOMEPRAZOLE
|
A02BC05
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
esomeprazole
|
Alborzdarou
|
METRONIDAZOLE SUSPENSION ORAL 125 mg/5mL 120 mL
|
METRONIDAZOLE SUSPENSION ORAL 125 mg/5mL 120 mL
|
METRONIDAZOLE
|
P01AB01
|
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
ANTIPROTOZOALS
|
AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
|
Nitroimidazole derivatives
|
metronidazole
|
Darou Pakhsh
|
LIDOCAINE INJECTION, SOLUTION PARENTERAL 2 % 50 mL
|
LIDOCAINE HYDROCHLORIDE INJECTION, SOLUTION PARENTERAL 2 % 50 mL
|
LIDOCAINE HYDROCHLORIDE
|
C01BB01
|
CARDIOVASCULAR SYSTEM
|
CARDIAC THERAPY
|
ANTIARRHYTHMICS, CLASS I AND III
|
Antiarrhythmics, class Ib
|
lidocaine
|
Jalinous Pharmaceutical Co.
|
CYPROHEPTADINE-JALINOUS TABLET ORAL 4 mg
|
CYPROHEPTADINE HYDROCHLORIDE TABLET ORAL 4 mg
|
CYPROHEPTADINE HYDROCHLORIDE
|
R06AX02
|
RESPIRATORY SYSTEM
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
Other antihistamines for systemic use
|
cyproheptadine
|
Soha Pharmaceutical Co.
|
CLINDAXOHA CAPSULE ORAL 150 mg
|
CLINDAMYCIN (AS HYDROCHLORIDE) CAPSULE ORAL 150 mg
|
CLINDAMYCIN (AS HYDROCHLORIDE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Toliddaru Pharma. Co.
|
OFLOQUINOL TABLET ORAL 300 mg
|
OFLOXACIN TABLET ORAL 300 mg
|
OFLOXACIN
|
J01MA01
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Fluoroquinolones
|
ofloxacin
|
Faran Shimi Pharmaceutical Co.
|
FAROXY TABLET, EXTENDED RELEASE ORAL 10 mg
|
OXYCODONE HYDROCHLORIDE TABLET, EXTENDED RELEASE ORAL 10 mg
|
OXYCODONE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Iran Daru
|
HYDROCORTISONE OINTMENT TOPICAL 1 % 15 g
|
HYDROCORTISONE ACETATE OINTMENT TOPICAL 1 % 15 g
|
HYDROCORTISONE ACETATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Daana Pharma
|
ACETAGEL-C CAPSULE, LIQUID FILLED ORAL 300 mg/20 mg
|
ACETAMINOPHEN / CODEINE PHOSPHATE CAPSULE, LIQUID FILLED ORAL 300 mg/20 mg
|
ACETAMINOPHEN / CODEINE PHOSPHATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Nano Daru Pajuhan Pardis
|
TRASTUZUMAB EMTANSINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 100 mg mg
|
TRASTUZUMAB EMTANSINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION PARENTERAL 100 mg
|
TRASTUZUMAB EMTANSINE
| null | null | null | null | null | null |
Behsa Pharmaceutical
|
BEHSADIN SOLUTION TOPICAL 10 % 1000 L
|
POVIDONE IODINE SOLUTION TOPICAL 10 % 1000 mL
|
POVIDONE IODINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Behvazan Pharmaceutical
|
GLYCERIN-BEHVAZAN SUPPOSITORY RECTAL 1 g
|
GLYCERIN SUPPOSITORY RECTAL 1 g
|
GLYCERIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Bakhtar Bioshimi
|
BIOQUETIN TABLET ORAL 150 mg
|
QUETIAPINE FUMARATE TABLET ORAL 150 mg
|
QUETIAPINE FUMARATE
|
N05AH04
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANTIPSYCHOTICS
|
Diazepines, oxazepines, thiazepines and oxepines
|
quetiapine
|
Loghman Pharmaceutical & Hygienic (public)
|
TADAREX TABLET ORAL 20 mg
|
TADALAFIL TABLET ORAL 20 mg
|
TADALAFIL
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Laboratorios Normon Sa
|
FLUCONAZOLE NORMON INJECTION PARENTERAL 2 mg/1mL 100 mg
|
FLUCONAZOLE INJECTION PARENTERAL 2 mg/1mL 100 mL
|
FLUCONAZOLE
|
J02AC01
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIMYCOTICS FOR SYSTEMIC USE
|
ANTIMYCOTICS FOR SYSTEMIC USE
|
Triazole derivatives
|
fluconazole
|
Caspian Tamin Co.
|
TRIFLUZIC INJECTION INTRAMUSCULAR 1 mg/1mL mL
|
TRIFLUOPERAZINE INJECTION INTRAMUSCULAR 1 mg/1mL
|
TRIFLUOPERAZINE
|
N05AB06
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANTIPSYCHOTICS
|
Phenothiazines with piperazine structure
|
trifluoperazine
|
Donyaye Behdasht Labs.co
|
DB-SALINE SPRAY NASAL 0.65 % 20 mL
|
SODIUM CHLORIDE SPRAY NASAL 0.65 % 20 mL
|
SODIUM CHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Teb-mofid-nikan
|
FUROSEMIDE TABLET ORAL 40 mg
|
FUROSEMIDE TABLET ORAL 40 mg
|
FUROSEMIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Hakim Pharmaceutical Co.
|
SIMVASTATIN-HAKIM TABLET ORAL 20 mg
|
SIMVASTATIN TABLET ORAL 20 mg
|
SIMVASTATIN
|
C10AA01
|
CARDIOVASCULAR SYSTEM
|
LIPID MODIFYING AGENTS
|
LIPID MODIFYING AGENTS, PLAIN
|
HMG CoA reductase inhibitors
|
simvastatin
|
Tasnim Pharmaceutical
|
FENOFEXINE TABLET ORAL 180 mg
|
FEXOFENADINE HYDROCHLORIDE TABLET ORAL 180 mg
|
FEXOFENADINE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Hakim Pharmaceutical Co.
|
MIGRAKIM TABLET ORAL 50 mg
|
SUMATRIPTAN (AS SUCCINATE) TABLET ORAL 50 mg
|
SUMATRIPTAN (AS SUCCINATE)
|
N02CC01
|
NERVOUS SYSTEM
|
ANALGESICS
|
ANTIMIGRAINE PREPARATIONS
|
Selective serotonin (5HT1) agonists
|
sumatriptan
|
Sajad Daru Shargh
|
FOLIC ACID TABLET ORAL 5 mg
|
FOLIC ACID TABLET ORAL 5 mg
|
FOLIC ACID
|
B03BB01
|
BLOOD AND BLOOD FORMING ORGANS
|
ANTIANEMIC PREPARATIONS
|
VITAMIN B12 AND FOLIC ACID
|
Folic acid and derivatives
|
folic acid
|
Darou Pakhsh
|
HEPARIN INJECTION PARENTERAL 5000 [iU]/1mL 1 mL
|
HEPARIN SODIUM INJECTION PARENTERAL 5000 [iU]/1mL 1 mL
|
HEPARIN SODIUM
|
B01AB01
|
BLOOD AND BLOOD FORMING ORGANS
|
ANTITHROMBOTIC AGENTS
|
ANTITHROMBOTIC AGENTS
|
Heparin group
|
heparin
|
Zahravi Pharmaceutical
|
A-VITIN CAPSULE, LIQUID FILLED ORAL 50000 [iU]
|
VITAMIN A CAPSULE, LIQUID FILLED ORAL 50000 [iU]
|
VITAMIN A
|
A11CA01
|
ALIMENTARY TRACT AND METABOLISM
|
VITAMINS
|
VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO
|
Vitamin A, plain
|
retinol (vit A)
|
Soha Pharmaceutical Co.
|
ACETAMINOPHEN SOHA TABLET ORAL 325 mg
|
ACETAMINOPHEN TABLET ORAL 325 mg
|
ACETAMINOPHEN
|
N02BE01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol
|
Sobhandarou
|
IMIPRAMINE TABLET ORAL 25 mg
|
IMIPRAMINE HYDROCHLORIDE TABLET ORAL 25 mg
|
IMIPRAMINE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Caspian Tamin Co.
|
IPANTHEN CREAM TOPICAL 5 % 30 g
|
DEXPANTHENOL CREAM TOPICAL 5 % 30 g
|
DEXPANTHENOL
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Alborzdarou
|
ACETAMINOPHEN TABLET ORAL 500 mg
|
ACETAMINOPHEN TABLET ORAL 500 mg
|
ACETAMINOPHEN
|
N02BE01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol
|
Aryapharmaceutical
|
MESALAZINE ARYA TABLET, DELAYED RELEASE ORAL 500 mg
|
MESALAZINE TABLET, DELAYED RELEASE ORAL 500 mg
|
MESALAZINE
|
A07EC02
|
ALIMENTARY TRACT AND METABOLISM
|
ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
|
INTESTINAL ANTIINFLAMMATORY AGENTS
|
Aminosalicylic acid and similar agents
|
mesalazine
|
Iran Avandfar
|
AFINDAMAYCIN SOLUTION TOPICAL 10 mg/1mL 60 mL
|
CLINDAMYCIN (AS PHOSPHATE) SOLUTION TOPICAL 10 mg/1mL 60 mL
|
CLINDAMYCIN (AS PHOSPHATE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Dorsa darou
|
AZITHROMYCIN POWDER, FOR SUSPENSION ORAL 100 mg/5mL 30 mL
|
AZITHROMYCIN POWDER, FOR SUSPENSION ORAL 100 mg/5mL 30 mL
|
AZITHROMYCIN
|
J01FA10
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
|
Macrolides
|
azithromycin
|
Sobhandarou
|
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg
|
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg
|
OMEPRAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Gilaranco
|
LINDALICE SHAMPOO TOPICAL 1 % 60 mL
|
LINDANE SHAMPOO TOPICAL 1 % 60 mL
|
LINDANE
|
P03AB02
|
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
|
ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS
|
ECTOPARASITICIDES, INCL. SCABICIDES
|
Chlorine containing products
|
lindane
|
Sajad Daru Shargh
|
FOLIC ACID TABLET ORAL 1 mg
|
FOLIC ACID TABLET ORAL 1 mg
|
FOLIC ACID
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Shahid Ghazi Pharmaceutical Co.
|
SODIUM CHLORIDE SOLUTION IRRIGATION 0.9 % 500 mL
|
SODIUM CHLORIDE SOLUTION IRRIGATION 0.9 % 500 mL
|
SODIUM CHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Tehran Chemie Pharmaceutical Co.
|
LEVICETAM TABLET ORAL 500 mg
|
LEVETIRACETAM TABLET ORAL 500 mg
|
LEVETIRACETAM
|
N03AX14
|
NERVOUS SYSTEM
|
ANTIEPILEPTICS
|
ANTIEPILEPTICS
|
Other antiepileptics
|
levetiracetam
|
NO.115 , Jalal St ., Esteqlal Town ,Tehran
|
FAMOTIDINE TABLET ORAL 20 mg
|
FAMOTIDINE TABLET ORAL 20 mg
|
FAMOTIDINE
|
A02BA03
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
H2-receptor antagonists
|
famotidine
|
Mina Pharmaceutical&cosmetics Laboratory
|
MINAPERAZIN SYRUP ORAL 750 mg/5 mL 60 mL
|
PIPERAZINE SYRUP ORAL 750 mg/5 mL 60 mL
|
PIPERAZINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Mina Pharmaceutical&cosmetics Laboratory
|
MINAPERAZIN SYRUP ORAL 750 mg/5 mL 60 mL
|
PIPERAZINE SYRUP ORAL 750 mg/5 mL 60 mL
|
PIPERAZINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Tehran Chemie Pharmaceutical Co.
|
HYOTEX TABLET ORAL 10 mg
|
HYOSCINE-N-BUTYL BROMIDE TABLET ORAL 10 mg
|
HYOSCINE-N-BUTYL BROMIDE
|
A03BB01
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
BELLADONNA AND DERIVATIVES, PLAIN
|
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
|
butylscopolamine
|
Pars Darou
|
LEVOFLOXACIN TABLET ORAL 750 mg
|
LEVOFLOXACIN TABLET ORAL 750 mg
|
LEVOFLOXACIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
شرکت دارو سازی یاس کویرمیبد
|
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg
|
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg
|
OMEPRAZOLE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Behsa Pharmaceutical
|
ACETAMINOPHEN BEHSA SOLUTION ORAL 120 mg/5mL 60 mL
|
ACETAMINOPHEN SOLUTION ORAL 120 mg/5mL 60 mL
|
ACETAMINOPHEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Behvazan Pharmaceutical
|
CLOTRIMAZOLE/BETAMETHAZONE-BEHVAZAN CREAM TOPICAL 1 %/0.05 % 45 g
|
CLOTRIMAZOLE / BETAMETHASONE (AS DIPROPIONATE) CREAM TOPICAL 1 %/0.05 % 45 g
|
CLOTRIMAZOLE / BETAMETHASONE (AS DIPROPIONATE)
|
D07CC01
|
DERMATOLOGICALS
|
CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
|
CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS
|
Corticosteroids, potent, combinations with antibiotics
|
betamethasone and antibiotics
|
Shahre Daru
|
ACETAMINOPHEN TABLET ORAL 500 mg
|
ACETAMINOPHEN TABLET ORAL 500 mg
|
ACETAMINOPHEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Darou Pakhsh
|
METOCLOPRAMIDE INJECTION PARENTERAL 5 mg/1mL 2 mL
|
METOCLOPRAMIDE INJECTION PARENTERAL 5 mg/1mL 2 mL
|
METOCLOPRAMIDE
|
A03FA01
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
PROPULSIVES
|
Propulsives
|
metoclopramide
|
Aburaihan Pharmaceutical Co
|
KETOROLAC TABLET ORAL 10 mg
|
KETOROLAC TROMETAMOL TABLET ORAL 10 mg
|
KETOROLAC TROMETAMOL
|
M01AB15
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Acetic acid derivatives and related substances
|
ketorolac
|
Elfin Pvt Ltd
|
FLUTIN CAPSULE ORAL 20 mg
|
FLUOXETINE (AS HYDROCHLORIDE) CAPSULE ORAL 20 mg
|
FLUOXETINE (AS HYDROCHLORIDE)
|
N06AB03
|
NERVOUS SYSTEM
|
PSYCHOANALEPTICS
|
ANTIDEPRESSANTS
|
Selective serotonin reuptake inhibitors
|
fluoxetine
|
Teb-mofid-nikan
|
MODAFENAC CAPSULE, EXTENDED RELEASE ORAL 100 mg
|
DICLOFENAC SODIUM CAPSULE, EXTENDED RELEASE ORAL 100 mg
|
DICLOFENAC SODIUM
|
M01AB05
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Acetic acid derivatives and related substances
|
diclofenac
|
Pharmachemie
|
LEVOFLOXACIN TABLET ORAL 750 mg
|
LEVOFLOXACIN TABLET ORAL 750 mg
|
LEVOFLOXACIN
|
J01MA12
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Fluoroquinolones
|
levofloxacin
|
Fanavarihaye Novin Darouie Atieh
|
MEBECOL TABLET ORAL 135 mg
|
MEBEVERINE HYDROCHLORIDE TABLET ORAL 135 mg
|
MEBEVERINE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Iran Najo
|
CALAMINE-NAJO CREAM TOPICAL 8 % 30 g
|
CALAMINE CREAM TOPICAL 8 % 30 g
|
CALAMINE
|
D02AB
|
DERMATOLOGICALS
|
EMOLLIENTS AND PROTECTIVES
|
EMOLLIENTS AND PROTECTIVES
|
Zinc products
| null |
Tehran Darou Pharmaceutical Co.
|
ATENOLOL-TEDAPHARM TABLET ORAL 100 mg
|
ATENOLOL TABLET ORAL 100 mg
|
ATENOLOL
|
C07AB03
|
CARDIOVASCULAR SYSTEM
|
BETA BLOCKING AGENTS
|
BETA BLOCKING AGENTS
|
Beta blocking agents, selective
|
atenolol
|
Mehr Darou
|
BUPRENORPHINE TABLET SUBLINGUAL 2 mg
|
BUPRENORPHINE (AS HYDROCHLORIDE) TABLET SUBLINGUAL 2 mg
|
BUPRENORPHINE (AS HYDROCHLORIDE)
|
N07BC01
|
NERVOUS SYSTEM
|
OTHER NERVOUS SYSTEM DRUGS
|
DRUGS USED IN ADDICTIVE DISORDERS
|
Drugs used in opioid dependence
|
buprenorphine
|
Sobhandarou
|
LEXATAL TABLET ORAL 10 mg
|
ESCITALOPRAM (AS OXALATE) TABLET ORAL 10 mg
|
ESCITALOPRAM (AS OXALATE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Kishmedipharm
|
CLOTRIMAZOLE MEDIPHARM CREAM VAGINAL 1 % 50 g
|
CLOTRIMAZOLE CREAM VAGINAL 1 % 50 g
|
CLOTRIMAZOLE
|
G01AF02
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
|
ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
|
Imidazole derivatives
|
clotrimazole
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.